Literature DB >> 27286135

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer.

Ahmed E Hegab1, Naofumi Kameyama2, Aoi Kuroda2, Shizuko Kagawa2, Yongjun Yin3, David Ornitz3, Tomoko Betsuyaku2.   

Abstract

Lung cancer is the most lethal cancer in the world. Intensive research is ongoing worldwide to identify new therapies for lung cancer. Several mouse models of lung cancer are being used to study the mechanism of cancer development and to experiment with various therapeutic strategies. However, the absence of a real-time technique to identify the development of tumor nodules in mice lungs and to monitor the changes in their size in response to various experimental and therapeutic interventions hampers the ability to obtain an accurate description of the course of the disease and its timely response to treatments. In this study, a method using a micro-computed tomography (CT) scanner for the detection of the development of lung tumors in a mouse model of lung adenocarcinoma is described. Next, we show that monthly follow-up with micro-CT can identify dynamic changes in the lung tumor, such as the appearance of additional nodules, increase in the size of previously detected nodules, and decrease in the size or complete resolution of nodules in response to treatment. Finally, the accuracy of this real-time assessment method was confirmed with end-point histological quantification. This technique paves the way for planning and conducting more complex experiments on lung cancer animal models, and it enables us to better understand the mechanisms of carcinogenesis and the effects of different treatment modalities while saving time and resources.

Entities:  

Mesh:

Year:  2016        PMID: 27286135      PMCID: PMC4927707          DOI: 10.3791/53904

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  13 in total

1.  Noninvasive bioluminescence imaging in small animals.

Authors:  Kurt R Zinn; Tandra R Chaudhuri; April Adams Szafran; Darrell O'Quinn; Casey Weaver; Kari Dugger; Dale Lamar; Robert A Kesterson; Xiangdong Wang; Stuart J Frank
Journal:  ILAR J       Date:  2008

Review 2.  Lost in translation: animal models and clinical trials in cancer treatment.

Authors:  Isabella Wy Mak; Nathan Evaniew; Michelle Ghert
Journal:  Am J Transl Res       Date:  2014-01-15       Impact factor: 4.060

3.  Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma.

Authors:  Daisuke Arai; Ahmed E Hegab; Kenzo Soejima; Aoi Kuroda; Kota Ishioka; Hiroyuki Yasuda; Katsuhiko Naoki; Kagawa Shizuko; Junko Hamamoto; Yongjun Yin; David M Ornitz; Tomoko Betsuyaku
Journal:  J Pathol       Date:  2014-12-17       Impact factor: 7.996

Review 4.  Overview: engineering transgenic constructs and mice.

Authors:  Naoto Haruyama; Andrew Cho; Ashok B Kulkarni
Journal:  Curr Protoc Cell Biol       Date:  2009-03

Review 5.  Mouse models for lung cancer.

Authors:  Min-chul Kwon; Anton Berns
Journal:  Mol Oncol       Date:  2013-02-19       Impact factor: 6.603

6.  Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.

Authors:  Angélica M Santos; Jason Jung; Nazneen Aziz; Joseph L Kissil; Ellen Puré
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

7.  Rapid induction of lung adenocarcinoma by fibroblast growth factor 9 signaling through FGF receptor 3.

Authors:  Yongjun Yin; Tomoko Betsuyaku; Joel R Garbow; Jinbai Miao; Ramaswamy Govindan; David M Ornitz
Journal:  Cancer Res       Date:  2013-07-18       Impact factor: 12.701

8.  Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis.

Authors:  Allison N Lau; Stephen J Curtis; Christine M Fillmore; Samuel P Rowbotham; Morvarid Mohseni; Darcy E Wagner; Alexander M Beede; Daniel T Montoro; Kerstin W Sinkevicius; Zandra E Walton; Juliana Barrios; Daniel J Weiss; Fernando D Camargo; Kwok-Kin Wong; Carla F Kim
Journal:  EMBO J       Date:  2014-02-04       Impact factor: 11.598

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 10.  The genetic basis of susceptibility to lung tumors in mice.

Authors:  A M Malkinson
Journal:  Toxicology       Date:  1989-03       Impact factor: 4.221

View more
  2 in total

Review 1.  Preclinical Applications of Multi-Platform Imaging in Animal Models of Cancer.

Authors:  Natalie J Serkova; Kristine Glunde; Chad R Haney; Mohammed Farhoud; Alexandra De Lille; Elizabeth F Redente; Dmitri Simberg; David C Westerly; Lynn Griffin; Ralph P Mason
Journal:  Cancer Res       Date:  2020-12-01       Impact factor: 13.312

2.  Lung Volume Calculation in Preclinical MicroCT: A Fast Geometrical Approach.

Authors:  Juan Antonio Camara; Anna Pujol; Juan Jose Jimenez; Jaime Donate; Marina Ferrer; Greetje Vande Velde
Journal:  J Imaging       Date:  2022-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.